标题
Integrative discovery of treatments for high-risk neuroblastoma
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-01-03
DOI
10.1038/s41467-019-13817-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Spontaneous regression of neuroblastoma
- (2018) Garrett M. Brodeur CELL AND TISSUE RESEARCH
- The landscape of genomic alterations across childhood cancers
- (2018) Susanne N. Gröbner et al. NATURE
- RAS-MAPK pathway-driven tumor progression is associated with loss of CIC and other genomic aberrations in neuroblastoma
- (2018) Thomas F Eleveld et al. CANCER RESEARCH
- DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
- (2018) Chaoyang Ye et al. Nature Communications
- Neuroblastoma is composed of two super-enhancer-associated differentiation states
- (2017) Tim van Groningen et al. NATURE GENETICS
- Rho-associated kinase is a therapeutic target in neuroblastoma
- (2017) Cecilia Dyberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FC1000: normalized gene expression changes of systematically perturbed human cells
- (2017) Ingrid M. Lönnstedt et al. Statistical Applications in Genetics and Molecular Biology
- PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens
- (2017) Erin C. Bush et al. Nature Communications
- Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
- (2017) Marjolein Soethoudt et al. Nature Communications
- FC1000: normalized gene expression changes of systematically perturbed human cells
- (2017) Ingrid M. Lönnstedt et al. Statistical Applications in Genetics and Molecular Biology
- Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
- (2017) Camilla U. Persson et al. Scientific Reports
- JWH-133, a Selective Cannabinoid CB2 Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells
- (2016) Jakub Wojcieszak et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd
- (2016) Zichen Wang et al. Nature Communications
- Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients
- (2016) Diogo Ribeiro et al. Cell Reports
- Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma
- (2016) Teresia Kling et al. EBioMedicine
- Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
- (2016) Zhenghu Chen et al. Scientific Reports
- GEO2Enrichr: browser extension and server app to extract gene sets from GEO and analyze them for biological functions: Fig. 1.
- (2015) Gregory W. Gundersen et al. BIOINFORMATICS
- Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment
- (2015) I. Lambertz et al. CLINICAL CANCER RESEARCH
- Advances in Risk Classification and Treatment Strategies for Neuroblastoma
- (2015) Navin R. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- Efficient exploration of pan-cancer networks by generalized covariance selection and interactive web content
- (2015) Teresia Kling et al. NUCLEIC ACIDS RESEARCH
- STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data
- (2015) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
- (2015) D. Fey et al. Science Signaling
- Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
- (2015) D. Fey et al. Science Signaling
- The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
- (2015) Yuan Xie et al. EBioMedicine
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- The characteristic direction: a geometrical approach to identify differentially expressed genes
- (2014) Neil R Clark et al. BMC BIOINFORMATICS
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours
- (2014) Noémie Braekeveldt et al. INTERNATIONAL JOURNAL OF CANCER
- The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
- (2014) Charles Wang et al. NATURE BIOTECHNOLOGY
- Full-length RNA-seq from single cells using Smart-seq2
- (2014) Simone Picelli et al. Nature Protocols
- MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells
- (2014) L Guglielmi et al. Cell Death & Disease
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
- (2012) Shizhen Zhu et al. CANCER CELL
- Discovery of Potent and Selective Covalent Inhibitors of JNK
- (2012) Tinghu Zhang et al. CHEMISTRY & BIOLOGY
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor
- (2011) Véronique Plantevin Krenitsky et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Network modeling of the transcriptional effects of copy number aberrations in glioblastoma
- (2011) R. Jornsten et al. Molecular Systems Biology
- The MYCN oncogene and differentiation in neuroblastoma
- (2011) Ulrica K. Westermark et al. SEMINARS IN CANCER BIOLOGY
- In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB 1 receptor antagonist for the management of obesity
- (2010) John R. Hadcock et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- In vivo effects of rosiglitazone in a human neuroblastoma xenograft
- (2010) I Cellai et al. BRITISH JOURNAL OF CANCER
- Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo
- (2010) Kristen N. Richards et al. CANCER
- Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
- (2010) K. De Preter et al. CLINICAL CANCER RESEARCH
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
- (2009) Steven M. Pollard et al. Cell Stem Cell
- Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation
- (2009) Jussi Hirvonen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now